| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |